These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 6797063)
1. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation]. Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063 [TBL] [Abstract][Full Text] [Related]
2. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC). Tran TH; Lämmle B; Duckert F Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209 [TBL] [Abstract][Full Text] [Related]
3. [Factor VIII complex activities in acute leukemia]. Pniejnia-Olszyński W; Lopaciuk S Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320 [TBL] [Abstract][Full Text] [Related]
4. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [TBL] [Abstract][Full Text] [Related]
5. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results]. Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120). Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753 [TBL] [Abstract][Full Text] [Related]
7. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783 [TBL] [Abstract][Full Text] [Related]
8. A critical evaluation of the available methods for the determination of factor VIII von Willebrand. Casonato A; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633 [TBL] [Abstract][Full Text] [Related]
9. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules. Furlan M; Perret BA; Beck EA Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease. Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740 [TBL] [Abstract][Full Text] [Related]
11. [Stability of ristocetin cofactor and factor VIII associated antigen in relation to storage conditions]. Töpfer G; Lutze G; Schmidt LH; Friedel G; Seifert A; Novy EM; Lehmann L Z Med Lab Diagn; 1983; 24(8):463-8. PubMed ID: 6424351 [No Abstract] [Full Text] [Related]
13. Quantitative and qualitative assessment of plasma von Willebrand factor variations, as induced by forearm venous stasis in patients with diabetic microangiopathy. Porta M; Ricchetti I; La Selva M; Bertagna A; Molinatti GM Diabetes Res; 1984 Nov; 1(4):219-21. PubMed ID: 6442228 [TBL] [Abstract][Full Text] [Related]
14. Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity. Gralnick HR J Clin Invest; 1978 Aug; 62(2):496-9. PubMed ID: 307560 [TBL] [Abstract][Full Text] [Related]
15. [Electrophoretic properties of the factor VIII/vW complex in liver disease (author's transl)]. Vicente García VU; Alberca Silva I; Moraleda Jiménez JM; López Borrasca A Sangre (Barc); 1980; 25(4):471-8. PubMed ID: 6775380 [No Abstract] [Full Text] [Related]
16. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex. Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443 [TBL] [Abstract][Full Text] [Related]
17. Measurement of canine von Willebrand factor using ristocetin and Polybrene. Diagnosis of canine von Willebrand's disease. Rosborough TK; Johnson GS; Benson RE; Swaim WR; Dodds WJ J Lab Clin Med; 1980 Jul; 96(1):47-56. PubMed ID: 6967101 [TBL] [Abstract][Full Text] [Related]
18. Antihaemophilic factor A activity, F VIII-related antigen and von Wilebrand factor in hepatic cirrhosis. Baele G; Matthijs E; Barbier F Acta Haematol; 1977; 57(5):290-7. PubMed ID: 403732 [TBL] [Abstract][Full Text] [Related]
19. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography. Orthner CL J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416 [TBL] [Abstract][Full Text] [Related]
20. [Studies on the dynamics of plasma factor VIII/von Willebrand factor activity in cerebrovascular diseases]. Shinmyozu K; Maruyama Y; Ohkatsu Y; Maruyama I; Igata A Rinsho Shinkeigaku; 1983 Feb; 23(2):172-9. PubMed ID: 6407797 [No Abstract] [Full Text] [Related] [Next] [New Search]